← Back to all trials
Recruiting
NCT06685497
COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
Conditions: Colorectal Carcinoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 236
Sponsor: RenJi Hospital
Location: Shanghai Jiao Tong University School of Medicine, Renji Hospital Shanghai
Summary
This is a single-center, prospective, interventional study. A total of 236 colorectal cancer patients who underwent surgery will be enrolled and followed for 52 weeks. The digital healthcare quality management system, based on the COLORECTUM+ model, will be used for post-treatment quality evaluation and continuous improvement.
Patients will be managed using an Internet+ post-treatment healthcare management platform. The platform integrates AI technology for real-time symptom analysis and alerts. Patients will report symptoms and health data through the platform, which will generate alerts based on symptom severity to guide appropriate interventions. Follow-up assessments will include patient adherence, satisfaction, quality of life, and healthcare utilization.
The study expects to demonstrate that the digital healthcare quality management system improves follow-up rates, enhances patient adherence, reduces unplanned hospital visits, and increases overall patient satisfaction. The findings aim to provide evidence for the implementation of digital management systems in colorectal cancer post-treatment care, potentially leading to improved long-term outcomes for patients.
Eligibility Criteria
Inclusion Criteria:
* Over 18 years old.
* Pathologically confirmed colorectal cancer patients.
* Underwent surgery at the Colorectal Cancer Diagnosis and Treatment Center, Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
* Signed informed consent form.
Exclusion Criteria:
* Unable to access electronic devices that can connect to the internet or mobile communications.
* Uncontrolled psychiatric illness.
* The ECOG score is greater than or equal to 3.
* Deemed unsuitable for participation by the investigator.
Source: ClinicalTrials.gov (NCT06685497). StuddyBuddy aggregates publicly available trial information.